JPH0470285B2 - - Google Patents

Info

Publication number
JPH0470285B2
JPH0470285B2 JP61235451A JP23545186A JPH0470285B2 JP H0470285 B2 JPH0470285 B2 JP H0470285B2 JP 61235451 A JP61235451 A JP 61235451A JP 23545186 A JP23545186 A JP 23545186A JP H0470285 B2 JPH0470285 B2 JP H0470285B2
Authority
JP
Japan
Prior art keywords
piroxicam
acetyl
salt
methionine
guanylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61235451A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6296424A (ja
Inventor
Chaaruzu Kuroofuoodo Toomasu
Rii Raason Deebitsudo
Jooji Ronbaadeino Josefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS6296424A publication Critical patent/JPS6296424A/ja
Publication of JPH0470285B2 publication Critical patent/JPH0470285B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
JP61235451A 1985-10-02 1986-10-02 改良された抗炎症組成物 Granted JPS6296424A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
WO85/01926 1985-10-02
US8501926 1985-10-02

Publications (2)

Publication Number Publication Date
JPS6296424A JPS6296424A (ja) 1987-05-02
JPH0470285B2 true JPH0470285B2 (de) 1992-11-10

Family

ID=22188870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61235451A Granted JPS6296424A (ja) 1985-10-02 1986-10-02 改良された抗炎症組成物

Country Status (15)

Country Link
US (1) US4994457A (de)
EP (1) EP0218453B1 (de)
JP (1) JPS6296424A (de)
KR (1) KR890001236B1 (de)
AT (1) ATE49121T1 (de)
AU (1) AU563822B2 (de)
CA (1) CA1273875A (de)
DE (1) DE3667914D1 (de)
DK (1) DK166343C (de)
GR (1) GR3000305T3 (de)
HU (1) HU207219B (de)
IE (1) IE58635B1 (de)
NZ (1) NZ217778A (de)
PT (1) PT83472B (de)
ZA (1) ZA867494B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6555141B1 (en) 1998-02-27 2003-04-29 Nutramax Laboratories, Inc. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
ES2388609T3 (es) * 2004-09-17 2012-10-16 Ajinomoto Co., Inc. Agente y alimento para prevenir y/o mejorar los trastornos digestivos funcionales
KR101821050B1 (ko) 2015-10-14 2018-03-09 씨제이제일제당 (주) 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
GB2078738B (en) * 1980-06-27 1983-11-30 Mitsui Toatsu Chemicals Benzothiazine derivatives
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4551452A (en) * 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
EP0178122B1 (de) * 1984-10-11 1991-06-05 Pfizer Inc. Piroxicam enthaltende entzündungshemmende Zusammensetzungen
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
ZA867494B (en) 1988-05-25
DK468486D0 (da) 1986-10-01
EP0218453B1 (de) 1990-01-03
CA1273875A (en) 1990-09-11
EP0218453A1 (de) 1987-04-15
NZ217778A (en) 1989-03-29
KR870003783A (ko) 1987-05-04
HU207219B (en) 1993-03-29
PT83472B (pt) 1989-05-31
DK166343C (da) 1993-09-06
AU563822B2 (en) 1987-07-23
DK468486A (da) 1987-04-03
GR3000305T3 (en) 1991-06-07
HUT46216A (en) 1988-10-28
PT83472A (en) 1986-11-01
DE3667914D1 (de) 1990-02-08
ATE49121T1 (de) 1990-01-15
AU6342186A (en) 1987-04-09
IE862599L (en) 1987-04-02
IE58635B1 (en) 1993-10-20
JPS6296424A (ja) 1987-05-02
DK166343B (da) 1993-04-13
KR890001236B1 (ko) 1989-04-28
US4994457A (en) 1991-02-19

Similar Documents

Publication Publication Date Title
US4446140A (en) Method and composition for treating mouth pain
EP1071430A1 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
WO1992021345A1 (en) Composition, method and kit for potentiating antitumor activity and for curing tumor
US20220323437A1 (en) Methods for treating pulmonary arterial hypertension
US4766117A (en) Antiinflammatory compositions and methods
JPS59112948A (ja) コレステロ−ルレベル低下剤
US4564614A (en) Antiinflammatory methods
JPH0470285B2 (de)
EP0399051B1 (de) Polyvalentes entzündungshemmendes mittel
US4252797A (en) Corticosteroid calcium compositions and treatment of rheumatic diseases therewith
EP0190851B1 (de) Entzündungshemmende Zusammensetzung
JP3982889B2 (ja) イブプロフェン含有医薬製剤
US4954505A (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
HU193845B (en) Process for preparing synergic pharmaceutical preparations comprising flupyrthine and 4-acetamido-phenol
US4874757A (en) Antinflammatory compositions and methods
JP2845988B2 (ja) ベンフォチアミン製剤
US4517309A (en) Method for the treatment of calcifying pancreatitis
CN1007959B (zh) 经改进的抗炎组合物的制备方法
US4812455A (en) Antiinflammatory compositions and methods
JPH1036258A (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
JPH10509729A (ja) 骨粗鬆症治療サイクル用キット
JPS6360926A (ja) 感冒薬
JPS6345371B2 (de)
JPS58167522A (ja) 経口投与性アスピリン調合剤
US20250161270A1 (en) Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor